TransMedics Group Inc logo

TransMedics Group Inc

NAS:TMDX (USA)  
$ 82.93 +1.33 (+1.63%) 03:24 PM EST
At Loss
P/B:
19.43
Volume:
697.97K
Avg Vol (2M):
590.06K
Also Trade In:
Volume:
697.97K
At Loss
Avg Vol (2M):
590.06K

Business Description

TransMedics Group Inc logo
TransMedics Group Inc
NAICS : 334510 SIC : 3845
ISIN : US89377M1099
Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Name Current Vs Industry Vs History
Cash-To-Debt 0.77
Equity-to-Asset 0.19
Debt-to-Equity 3.76
Debt-to-EBITDA -66.98
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.87
Distress
Grey
Safe
Beneish M-Score 2.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.21
9-Day RSI 42.81
14-Day RSI 45.33
6-1 Month Momentum % 30.69
12-1 Month Momentum % 7.12

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.3
Quick Ratio 8.49
Cash Ratio 7.19
Days Inventory 132.36
Days Sales Outstanding 71.9
Days Payable 33.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.3
Shareholder Yield % -12.97

Financials (Next Earnings Date:2024-05-01 Est.)

TMDX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TMDX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

TransMedics Group Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 241.623
EPS (TTM) ($) -0.77
Beta 2.1
Volatility % 118.72
14-Day RSI 45.33
14-Day ATR ($) 5.175531
20-Day SMA ($) 86.596
12-1 Month Momentum % 7.12
52-Week Range ($) 36.4201 - 99.63
Shares Outstanding (Mil) 32.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TransMedics Group Inc Filings

Filing Date Document Date Form
No Filing Data

TransMedics Group Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

TransMedics Group Inc Frequently Asked Questions

What is TransMedics Group Inc(TMDX)'s stock price today?
The current price of TMDX is $82.93. The 52 week high of TMDX is $99.63 and 52 week low is $36.42.
When is next earnings date of TransMedics Group Inc(TMDX)?
The next earnings date of TransMedics Group Inc(TMDX) is 2024-05-01 Est..
Does TransMedics Group Inc(TMDX) pay dividends? If so, how much?
TransMedics Group Inc(TMDX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1